Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability

Williams, S. Lloyd; Falbo, John

doi:10.1016/0005-7967(95)00063-1

Cited by 103 publications

(57 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cognitive-behavioural techniques were superior to waiting list control condition in a number of studies in panic disorder and/or agoraphobia (Barlow et al 1989;Gould and Clum 1995;Klosko et al 1990;Lidren et al 1994;Margraf et al 1993;Swinson et al 1995;Telch et al 1993Telch et al , 1995Williams and Falbo 1996), with one exception (Gould et al 1993). …”

Section: Monoamine Oxidase Inhibitors (Maoi)mentioning

confidence: 99%

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Bandelow

Zohar

Hollander

et al. 2008

The World Journal of Biological Psychiatry

712

410

View full text Add to dashboard Cite

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo-or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/ SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.

show abstract

Section: Monoamine Oxidase Inhibitors (Maoi)mentioning

confidence: 99%

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Bandelow

Zohar

Hollander

et al. 2008

The World Journal of Biological Psychiatry

712

410

View full text Add to dashboard Cite

show abstract

“…Additionally, all patients in this study were diagnosed with panic disorder and agoraphobia. This is important because the presence of agoraphobia has been found to influence the outcome of panic disorder (Williams & Falbo, 1996) and most previous studies included patients diagnosed with panic disorder with or without agoraphobia. In one exception, patients were treated with either a 14-session, 7-session, or group CBT and followed for two years (Marchand, Roberge, Primiano, & Germain, 2009).…”

mentioning

confidence: 99%

Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: A two-year follow-up study

Gloster

Hauke

Höfler

et al. 2013

Behaviour Research and Therapy

View full text Add to dashboard Cite

“…In vivo exposure has been found to not only address the problem of agoraphobic avoidance, but it has also been found to have a substantial impact on panic frequency, even in the absence of interventions specifically targeting these attacks (Cox et al, 1992;Williams & Falbo, 1996). The literature does seem consistent with a change route where a decrease in panic follows reductions in avoidance.…”

Section: Generalization Of Symptomsmentioning

confidence: 98%

“…However, as other ward activities were included in the treatment as well, the generality of this study is somewhat hampered. Williams and Falbo (1996) compared 8 sessions of cognitive therapy, guided mastery therapy, or the combination of both. The results showed that all treatments led to significant improvements, but on 3 out of 9 measures guided mastery therapy evidenced larger change scores than cognitive therapy.…”

Section: Cognitive Therapymentioning

confidence: 99%

Behavioral Treatments of Panic Disorder with Agoraphobia: Treatment Process and Determinants of Change

Ramnerö¹

2005

PsycEXTRA Dataset

View full text Add to dashboard Cite

The present dissertation comprises four empirical studies within the area of behavioral treatment of panic disorder with agoraphobia. The focus is on studying issues pertaining to outcome, treatment process and determinants of change. The first study is a randomized controlled treatment study of 73 patients undergoing 16 sessions of either exposure in vivo (E), or cognitive behavior therapy (CBT). Both treatments showed clear improvements at post-treatment that were well maintained at 1-year follow up, and there were no significant differences between the treatments. The second study concerned prediction of outcome in the same sample. From a variety of pre-treatment characteristics severity of avoidance was the one most related to outcome. Most predictors were found unrelated. Two approaches of prediction were also compared: treating outcome as a categorical vs. continuous variable. The different approaches yielded a somewhat dissimilar picture of the impact of pre-treatment severity of avoidance. The third study examined different aspects of the therapeutic relationship, and their relation to outcome. Clients' perceptions of therapists and their ratings of the working alliance were generally not related to outcome at any point. On the other hand, therapists' perceptions of patients as showing goal-direction and active participation were related to outcome from early on in therapy. The fourth study examined different aspects of change. It was found that change in indices of the frequency of panic attacks was not closely related to change in agoraphobic avoidance at post-treatment. Change in avoidance was also more related to other aspects of outcome. At one-year follow-up, a more unitary picture, regarding the different aspects of change was observed.

show abstract

Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability

Cited by 103 publications

References 32 publications

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: A two-year follow-up study

Behavioral Treatments of Panic Disorder with Agoraphobia: Treatment Process and Determinants of Change

Contact Info

Product

Resources

About